Who are paroxetine + aerobic exercise's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/paroxetine-aerobic-exercise.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

paroxetine + aerobic exercise — Competitive Intelligence Brief

paroxetine + aerobic exercise (paroxetine + aerobic exercise) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: SSRI + behavioral intervention. Area: Psychiatry / Mental Health.

marketed SSRI + behavioral intervention Serotonin transporter (SERT) Psychiatry / Mental Health Small molecule Live · refreshed every 30 min

Target snapshot

paroxetine + aerobic exercise (paroxetine + aerobic exercise) — University of Göttingen. Paroxetine increases serotonin availability in the brain while aerobic exercise enhances neuroplasticity and mood regulation through multiple physiological pathways.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
paroxetine + aerobic exercise TARGET	paroxetine + aerobic exercise	University of Göttingen	marketed	SSRI + behavioral intervention	Serotonin transporter (SERT)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (SSRI + behavioral intervention class)

University of Göttingen · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). paroxetine + aerobic exercise — Competitive Intelligence Brief. https://druglandscape.com/ci/paroxetine-aerobic-exercise. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab